Immunogenicity of HIV-1 gp140 - microbicide mixtures in mice using a vaginal delivery model

Immunogenicity of HIV-1 gp140 - microbicide mixtures in mice using a vaginal delivery model

Opis bibliograficzny
Główni autorzy:	Wegmann, F, Krashias, G, Profy, A, Jeffs, SA, Shattock, R, Sattentau, Q
Format:	Conference item
Wydane:	2007

Podobne zapisy

P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine
od: Giemza E, i wsp.
Wydane: (2009-10-01)

Vaginal Delivery of a Recombinant HIV-1 Clade-C Trimeric gp140 within Novel Rheologically Structured Vehicles Induces Specific Immune Responses
od: Curran, R, i wsp.
Wydane: (2008)

Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.
od: Krashias, G, i wsp.
Wydane: (2010)

A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment.
od: Wegmann, F, i wsp.
Wydane: (2011)

A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment
od: Wegmann, F, i wsp.
Wydane: (2011)

Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.
od: Arias, M, i wsp.
Wydane: (2011)

P19-54 LB. Interrogating the membrane-proximal external region (MPER) of HIV-1 gp140
od: Van Roey G, i wsp.
Wydane: (2009-10-01)

HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities.
od: Kelly E Seaton, i wsp.
Wydane: (2014-01-01)

Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens
od: Phindile Ximba, i wsp.
Wydane: (2020-04-01)

Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci.
od: Pruzina, S, i wsp.
Wydane: (2011)

Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci
od: Pruzina, S, i wsp.
Wydane: (2011)

P11-12. A novel vaginal ring device for the sustained delivery of recombinant C-clade HIV-1 CN54gp140
od: Shattock R, i wsp.
Wydane: (2009-10-01)

Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL.
od: Gözde Isik, i wsp.
Wydane: (2014-01-01)

Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens
od: Emmanuel Margolin, i wsp.
Wydane: (2019-10-01)

HIV-gp140 Antigen-Adsorbed Wax Nanoparticles Induce Strong In Vivo Systemic and Mucosal Humoral Immune Responses
od: Arias, M, i wsp.
Wydane: (2008)

Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
od: Sunil K Khattar, i wsp.
Wydane: (2013-01-01)

The development of vaginal microbicides for the prevention of HIV transmission.
od: Jonathan Weber, i wsp.
Wydane: (2005-05-01)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
Wydane: (2014-01-01)

Retraction: Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
od: PLOS ONE Editors
Wydane: (2020-01-01)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector.
od: Sunil K. Khattar, i wsp.
Wydane: (2014-01-01)

Vaginal microbicides: An overview
od: Hany Abdel-Aleem
Wydane: (2011-03-01)

P11-11. Stable lyophilised gel vehicles for vaginal administration of recombinant C-clade HIV-1 trimeric CN54gp140
od: Shattock RJ, i wsp.
Wydane: (2009-10-01)

A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment.
od: Frank Wegmann, i wsp.
Wydane: (2011-01-01)

Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
od: Jacques Ravel, i wsp.
Wydane: (2012-12-01)

P19-17. Construction of HIV-1 AE subtype gp140 DNA vaccine and immunogenicity evaluation
od: Wan Y, i wsp.
Wydane: (2009-10-01)

Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking.
od: Schiffner, T, i wsp.
Wydane: (2013)

Optimising CN54gp140 plasmid delivery by comparing intramuscular and intradermal vaccination combinations with and without electroporation
od: Mann JF, i wsp.
Wydane: (2012-09-01)

Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.
od: Kong, L, i wsp.
Wydane: (2010)

Expression-System-Dependent Modulation of HIV-1 Envelope Glycoprotein Antigenicity and Immunogenicity
od: Kong, L, i wsp.
Wydane: (2010)

Synergistic inhibition of HIV-1 infection by combinations of soluble polyanions with other potential microbicides.
od: Gantlett, K, i wsp.
Wydane: (2007)

P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens
od: Stamatatos L, i wsp.
Wydane: (2009-10-01)

Pharmaceutical Vehicles for Vaginal and Rectal Administration of Anti-HIV Microbicide Nanosystems
od: Letícia Mesquita, i wsp.
Wydane: (2019-03-01)

P11-09. Mucosal vaccination with a transferrin-gp140 conjugate via the nasal but not vaginal route elicits robust systemic and vaginal IgG and IgA responses
od: Shattock RJ, i wsp.
Wydane: (2009-10-01)

Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
od: Catherine A Cosgrove, i wsp.
Wydane: (2016-01-01)

Comparison of neutralizing antibody responses elicited from highly diverse polyvalent heterotrimeric HIV-1 gp140 cocktail immunogens versus a monovalent counterpart in rhesus macaques
od: Bowles, EJ, i wsp.
Wydane: (2014)

Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
od: Sven Kratochvil, i wsp.
Wydane: (2018-02-01)

HIV gp120: double lock strategy foils host defences.
od: Sattentau, Q
Wydane: (1998)

Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
od: Pool Robert, i wsp.
Wydane: (2009-10-01)

Microbicides 2006 conference
od: McGowan Ian, i wsp.
Wydane: (2006-10-01)

Which topical microbicides for blocking HIV-1 transmission will work in the real world?
od: Per Johan Klasse, i wsp.
Wydane: (2006-09-01)